Molecular target structures in alloxan-induced diabetes in mice

Life Sciences

Volumn 71, Issue 14, 2002, Pages 1681-1694

  Im Walde, Sabine Schulte ^a   Dohle, Claudia ^a   Schott Ohly, Patricia ^a   Gleichmann, Helga ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alloxan; Diabetes; Glucokinase; Glucose transporter 2; Streptozotocin

Indexed keywords

ALLOXAN; BETA ACTIN; DRINKING WATER; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; MESSENGER RNA; PROINSULIN; STREPTOZOCIN; THIOGLUCOSE; ZINC SULFATE;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; DOSE RESPONSE; DRUG EFFECT; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; REDUCTION; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

ALLOXAN; ANIMALS; ANTIMETABOLITES; BINDING SITES; BLOOD GLUCOSE; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLUCOKINASE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 2; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MONOSACCHARIDE TRANSPORT PROTEINS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ZINC;

ANIMALIA;

EID: 0037162981     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01918-5     Document Type: Article

References (41)

1. Late progression to diabetes and evidence for chronic β-cell autoimmunity in identical twins of patients with type 1 diabetes
2. Free radicals and diabetes
3. Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells
4. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress
5. Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice
6. Glucose transporter 2 in pancreatic islets: Crucial target molecule in diabetes induced with multiple-low-dose streptozotocin in mice
7. Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose
8. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin
9. Glutathione-mediated redox cycling of alloxan
10. Alloxan: History and mechanism of action
11. Metallothionein in isolated pancreatic islets of mice: Induction by zinc and streptozotocin, a naturally occuring diabetogen
12. Insulin recovery in pancreas and host organs of islet grafts
13. Singlestep method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
14. Procedures for cDNA cloning
15. Protective effects of metallothionein on streptozotocin-induced diabetes in rats
16. On the mechanism of glucose protection against alloxan toxicity
17. Glucose and alloxan interactions in the pancreatic islets
18. The inhibition of islet superoxide dismutase by diabetogenic drugs
19. Uptake of labeled alloxan in mouse organs and mitochondria in vivo and in vitro
20. Studies of alloxan toxicity on the beta cell
21. Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase
22. Site-specific DNA methylation and apoptosis: Induction by diabetogenic streptozotocin
23. Enhancement by streptozotocin of O2- radical generation by the xanthine oxidase system of pancreatic beta-cells
24. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type 1 diabetes
25. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues
26. Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait
27. Constitutive differences in antioxidant defense status distinguish alloxan-resistant and alloxan-susceptible mice
28. Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion
29. Resistance to alloxan of tumoral insulin-producing cells
30. 2+ in alloxan-induced pancreatic β-cell damage
31. STZ transport and cytotoxicity: Specific enhancement in GLUT2-expressing cells
32. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin
33. Mechanism of barbituric-acid protection against inhibition by alloxan of glucose-induced insulin release
34. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate
35. Contrasting effects of alloxan on islets and single mouse pancreatic β-cells
36. Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan
37. 2+ channels exposed to serum from patients with type I diabetes
38. The relationship between the physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives
39. 2+ transport
40. Protective mechanism of glucose against alloxan-induced pancreatic β-cell damage
41. Dietary zinc supplementation inhibits NF kappa B activation and protects against chemically induced diabetes in CD1 mice